LifeStance Health (LFST) Net Cash Flow (2020 - 2026)

LifeStance Health (LFST) has reported Net Cash Flow for 7 consecutive years, with -$53.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Cash Flow fell 166.1% year-over-year to -$53.8 million; the TTM figure through Mar 2026 stood at $60.5 million (down 28.77% YoY), while the FY2025 annual figure was $94.1 million, up 24.19% from the prior year.
• Net Cash Flow eased to -$53.8 million in Q1 2026 per LFST's latest filing, from $44.7 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $54.6 million in Q2 2025 and bottomed at -$53.8 million in Q1 2026.
• Historically, Net Cash Flow has averaged $2.8 million across 5 years, with a median of $11.3 million in 2023.
• Annual changes were most pronounced in 2023 — Net Cash Flow tumbled 482.68% — and 2024, when it jumped 231.69%.
• LifeStance Health's Net Cash Flow stood at $18.3 million in 2022, then surged by 98.08% to $36.2 million in 2023, then soared by 43.45% to $52.0 million in 2024, then fell by 13.89% to $44.7 million in 2025, then tumbled by 220.35% to -$53.8 million in 2026.
• Business Quant data shows LFST's Net Cash Flow at -$53.8 million in Q1 2026, $44.7 million in Q4 2025, and $15.0 million in Q3 2025.